/GTHP
GTHP Stock - Guided Therapeutics, Inc.
Healthcare|Medical - DevicesOTC
$0.35+9.38%
+$0.03 (+9.38%) • Dec 19
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.99
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.94
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.39
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GTHP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.35 – $0.35
TARGET (TP)$0.40
STOP LOSS$0.32
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.64
52W High$0.35
52W Low$0.06
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7,000 | $98,000 | $13,000 | $81,000 | $102,000 |
| Gross Profit | $2,000 | $36,000 | $-68,000 | $20,000 | $143,000 |
| Gross Margin | 28.6% | 36.7% | -523.1% | 24.7% | 140.2% |
| Operating Income | $-2,108,000 | $-3,457,000 | $-3,333,000 | $-2,362,000 | $-1,052,000 |
| Net Income | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 | $-279,000 |
| Net Margin | -34528.6% | -3560.2% | -33392.3% | -2555.6% | -273.5% |
| EPS | $-0.05 | $-0.07 | $-0.15 | $-0.18 | $-0.04 |
Company Overview
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GTHPBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | — | $-0.01 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.01 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.02 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 13, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-0.01 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-0.03 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.06 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.03 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.04 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.04 | — | — |
Q1 2022 | Mar 29, 2022 | — | $-0.03 | — | — |
Q4 2021 | Nov 15, 2021 | — | $0.01 | — | — |
Q3 2021 | Aug 18, 2021 | — | $-0.09 | — | — |
Q2 2021 | May 20, 2021 | — | $-0.05 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GTHP
What is GTHP's current stock price?
Guided Therapeutics, Inc. (GTHP) is currently trading at $0.35 per share. The stock has moved +9.38% today.
What is the analyst price target for GTHP?
No analyst price targets are currently available for this stock.
What sector is Guided Therapeutics, Inc. in?
Guided Therapeutics, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is GTHP's market cap?
Guided Therapeutics, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does GTHP pay dividends?
No, Guided Therapeutics, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACMSY
AccuStem Sciences Limited
$0.13
0ASAPF
Aurora Spine Corporation
$0.20
Mkt Cap: $0.0B
BTCY
Biotricity, Inc.
$0.39
Mkt Cap: $0.0B
CRVW
CareView Communications, Inc.
$0.02
Mkt Cap: $0.0B
EMITF
Elbit Imaging Ltd.
$0.05
Mkt Cap: $0.0B
IMMVF
Immunovia AB (publ)
$0.05
Mkt Cap: $0.0B
PYNKF
Perimeter Medical Imaging AI, Inc.
$0.24
Mkt Cap: $0.0B
UEEC
United Health Products, Inc.
$0.06
Mkt Cap: $0.0B
VPTDF
VentriPoint Diagnostics Ltd.
$0.09
Mkt Cap: $0.0B
ZHCLF
Zenith Capital Corp.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to GTHP for comparison